25 Ways to Prevent Cancer

Dr. David Byrd

Dr. David Byrd

Dr. David Byrd is a UW professor of surgery, the section chief of surgical oncology. In this video, he talks about how he focuses on the patient. Dr. Byrd understands the impact on patient lives when given a cancer diagnosis. Everything at SCCA has the patient in mind. From the moment a patient walks into the building, SCCA's treatment teams are there to support patient goals, including follow up plans and survivorship plans. SCCA personalizes treatment plans by taking what is known at an evidence-based level and tailoring it to patient goals.

Related Videos

Breast Cancer Breakthroughs

Dr. Byrd Discusses the Latest Breakthroughs in Breast Cancer Treatment According to Dr. David Byrd, one major breakthrough in breast cancer treatment is advancement in early detection. Surveillance is getting better resulting in earlier diagnosis, making breast cancer much more curable. He also discusses exciting new therapies that are able to target tumors allowing treatment of specific tumors using agents that use targeted chemotherapy or hormone therapy. Advancements in hormone treatment for breast cancer allow targeted therapy that helps keep tumors that make estrogen from dividing. This breakthrough is less destructive on the body overall with many less side effects. These advancements have had some exciting impact on breast cancer survival rates at SCCA. In general, breast cancer patients are surviving longer and cure rates are much higher at SCCA than at community hospitals. According to the National Cancer Data Base, SCCA's 5 year survival rates, stage for stage, are superior to other programs with small, medium or large cancer facilities.

Colon Cancer Treatment with Dr. David Byrd

Dr. David Byrd discusses treatment options for colon cancer. Most patients have surgery to remove their cancer, and chemotherapy to help prevent the cancer from coming back. Cancers that cannot be removed surgically can be controlled with chemotherapy. Biologic therapies are new medicines that attack cancer cells based on their biological features. These are sometimes called target therapies because they target cancer cells and spare normal cells, unlike most conventional chemotherapy. Survival reports from the National Cancer Data Base show that colon cancer patients who receive their first treatment at SCCA fare better compared to patients at other teaching or community hospitals.